| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.98B | +72.9% |
| Cost of Revenue | $902.6M | — |
| R&D Expense | $1.24B | -51.3% |
| SG&A Expense | $488.7M | +63.8% |
| Operating Income | -$644.7M | +61.8% |
| Interest Expense | $19.9M | -5.9% |
| Pre-tax Income | -$653.6M | +61.9% |
| Income Tax | $4.3M | -85.3% |
| Net Income | -$657.9M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.34B | -11.8% |
| Inventory | $36.7M | +313.5% |
| Current Assets | $1.70B | -21.0% |
| Total Assets | $2.26B | -12.3% |
| Current Liabilities | $2.46B | +2.9% |
| Total Liabilities | $2.89B | -1.2% |
| Stockholders' Equity | -$634.1M | -80.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$415.9M | -228.8% |
| Capital Expenditures | $89.1M | +63.4% |
| Investing Cash Flow | -$93.0M | -192.8% |
| Financing Cash Flow | $325.0M | -29.6% |
| Free Cash Flow | -$505.0M | -288.1% |
| +62.3% |
| EPS (Basic) | -$8.42 | +64.1% |
| EPS (Diluted) | -$8.42 | +64.1% |